Abstract: The aim of this study was to evaluate that: (i) epirubicin-HCl (EPI) and lymphokine-activated killer (LAK) cells cytotoxicity may be mediated by free radical generation; and (ii) resistant H1299 cells may be more sensitive to combined treatment of LAK cells plus EPI than the LAK or EPI treatment alone. Viability of H1299 cells treated with EPI, LAK and LAK plus EPI was measured using the MTT test. Amount of glutathione (GSH), protein content and enzymatic activity were measured by spectrophotometer. Glutathione S-transferase (GST)-pi expression in the cells was determined by western blot analysis. LAK plus EPI combined treatment increased susceptibility of H1299 WT and H1299 EPI(R) (300-fold EPI resistant) cells to LAK cell cytotoxicity. The resistance of H1299 EPI(R) cells to EPI appears to be associated with a developed tolerance to free radicals, most likely because of a 2-fold increase in NADPH-dependentcytochrome-P450 reductase (NADPH-CYP reductase) activity, 11-fold GST activity and 11-and 7-fold augmented selenium dependent and independent glutathione peroxidase (GSH-Px) activity, respectively. Amount of GST-pi in H1299 EPI(R) cells is statistically different from negative control and H1299 WT (p < 0.01). It is proposed that production of reactive oxygen species and hydrogen peroxide by the treatment of EPI and LAK cells can cause cytotoxicity of H1299 WT and H1299 EPI(R) cells. Superoxide dismutase, catalase, GSH-Px, GST, NADPH-CYP reductase and GSH must be considered as part of the intracellular antioxidant defense mechanism of H1299 WT and H1299 EPI(R) cells against reactive oxygen species. Combined treatment of EPI plus LAK cells caused the increasing cytotoxicity on the H1299 EPI(R) cells.
Introduction
The antracycline analogue epirubicin-HCl (EPI) is an intensely potent cytotoxic compound. It causes less cardiac injury than doxorubicin derivatives at doses producing equal antitumor activity. The proposed mechanism for their cytotoxic effects involves the formation of intracellular free radicals caused by the quinone group of antracycline (Dobbs et al. 1994) .
Glutathione peroxidase (GSH-Px), catalase and superoxide dismutase (SOD) protect the cells from the effects of reactive oxygen species generated during the one-electron reduction of quinines . Antioxidants and detoxification mechanisms that can be involved in the drug resistance of various tumors include glutathione (GSH), GSHPx and glutathione S-transferase (GST) . Natural killer (NK) cells exhibit cytotoxic activity against virus-infected cells and tumor cells. NK cells that were stimulated with interleukin 2 (IL-2) contribute to the lymphokine-activated killer (LAK) cell phenomenon (Fibeiro-Dias et al. 2000) . In the human non-small cell lung cancer (NSCLC), GSH played a vital role in the protection of trichloroethylene-and perchloroethylene-induced oxidative stress (Chen et al. 2002) .
We tested free radical-mediated cytotoxicity of EPI, LAK and LAK plus EPI (1/10 of the IC50 concentration) in H1299 WT and H1299 EPI(R) cells. The addition of a low concentration of EPI to LAK cells exposed to H1299 cells caused a significant increase in the susceptibility of H1299 WT and H1299 300-fold EPI resistant (EPI(R)) cells to LAK cells. Human lung cancer is probably a good candidate for the combination of immunotherapy and chemotherapy. • C for one minute. Cells were used when monolayer confluence had reached 75%. The EPI-resistant H1299 tumor cells were derived from the parental line by stepwise selection in increasing concentrations of EPI until the cells were capable of propagating in 30 ng/mL drug, as described previously (Jansson et al. 1999) . Typically, the resistant cells were grown in medium lacking EPI as minimum four passages before they were used in the experiments.
Material and methods

Drug and chemicals
Lymphocyte preparation and LAK cell generation. Venous blood was collected in heparinized vacutainer tubes from healthy adult donors. We prepared the mononuclear cells by centrifugation over Ficoll-Isopaque. Monocytes were depleted by incubation on plastic for 1 h at 37
• C. The nonadherent cell population was described as peripheral blood lymphocytes. They were activated by in vitro incubation for 4 days at 37
• C in Dulbecco's Modified Eagle Medium, 10 mM of L-glutamine, 10% autologous plasma, and 1,000 U/mL of recombinant IL-2, at a concentration of 1-2 × 10 6 /mL in 25 mL tissue culture flasks in a 5% CO2 environment. The recombinant IL-2 at 1,000 U/mL (Cetus) had been predetermined to yield maximum LAK cell generation (Grimm 1982) . H1299 WT and H1299 EPI(R) tumor cells were treated with LAK cells at different effector-cell/targetcell ratios for 24 h incubation.
MTT assay
Tumor cell cytotoxicity assays were conducted by seeding 50,000 cells/well in 6-chambered Linbro dishes (Costar) in complete medium. After 24 to 30 h, this medium was replaced with fresh medium containing the appropriate concentrations of EPI and/or number of LAK cells. H1299 cells were incubated in medium with 5% CO2 at 37
• C for 24 h. The MTT assay has been shown to be useful for measuring the cytotoxic activities of human NK/LAK cells (Hussain et al. 1993 ). This method was originally developed by Mossman (1983) . Tetrazolium salts such as MTT are metabolized by mitochondrial dehydrogenases to form a blue formazan dye and are therefore useful for the measurement of viability and cytotoxicity. Test reagents were added to the culture medium. In brief, a 15% volume of dye solution was added to each well and incubated with 5% CO2 at 37
• C for 1 h after the appropriate incubation time with EPI and/or LAK cells. Then, an equal volume of soluble/stop solution (dimethyl sulfoxide for the solubilization of formazan crystals) was added to each well. The absorbance of the reaction solution at 570 nm was recorded. The absorbance at 630 nm was used as a reference. The viability (%) was calculated by the formula (A570 nm − A630 nm) sample/(A570 nm − A630 nm) control × 100, and IC50 value of EPI, LAK and EPI plus LAK was calculated. For the investigation of the role of free radicals, H1299 WT and H1299 EPI(R) cells were preincubated with SOD (100 µg/mL) and catalase (50 units/mL) for 30 min, before EPI and LAK cells treatment.
Biochemical and enzymatic assays H1299 WT and H1299 EPI(R) tumor cells were scraped off the culture plates with trypsin-EDTA and were centrifuged at 400 × g for 10 min. The cell pellets were washed with phosphate-buffered saline (PBS) and then sonicated (3 × 15 sec) in 50 mM of potassium phosphate pH 7.2, containing 1 mM of PMSF (phenylmethylsulfonyl fluoride, Sigma) and 1 µg/mL of leupeptin (Sigma). Then they were centrifuged at 150,000 × g for 1 h. NADPH-cytochrome P-450 (CYP) reductase activity was assayed in the microsomal fractions, and all other parameters were assayed in the cytosolic fractions. The microsomal fractions were isolated by differential centrifugation techniques. NADPH-CYP reductase activities were assayed in the microsomal fractions from tumor cells using cytochrome c as an electron acceptor (Williams 1962) . GSH-Px activity was measured according to the method described by Paglia & Valentine (1967) . Selenium-dependent GSH-Px activity was assayed with 0.25 mM of H2O2 as a substrate, whereas total GSH-Px was measured with 1.2 mM of cumene hydroperoxide (Lawrence & Burk 1976) .
Total GSH content was determined by spectrophotometry following the reduction of 5,5-dithiobis(2-nitrobenzoic) acid by NADPH in the presence of GSSG-Rx (Beutler 1975) . Glutathione S-transferase was determined according to Habig & Jakoby (1974) using 1-chloro-2,4-dinitrophenol as a substrate. SOD activities were assayed in tumor cells sonicates by the method of McCord & Fridovich (1969) , using acetylcytochrome c modification as described by Azzi et al. (1975) . Protein determinations were done as recommended by Bradford (1976) .
Western blot analysis
Western blot analysis was modified from a previous study (Kotoh et al. 1993) . Tumor cells were collected by trypsinization, washed with PBS, lysed with lysis buffer (RIPA + protease inhibitor, Sigma P8340) and centrifuged (Centrifuge 5415). Suspended cells in the reducing sample buffer were boiled for 5 min at 95
• C, and 30 µg of protein per line was applied. The gel was electrophoresed for 1.5 h (90 V), and the protein was transferred onto Hybond-C nitrocellulose membrane. After blocking, the nitrocellulose membrane was incubated with primary antibody for GST-pi (mouse IgG1, G5920-050 pharming) followed by treatment with a secondary antibody (goat antimouse IgG-HRP, sc-2001) conjugated to horseradish peroxidase. The membrane was detected using the ECL system. Western blotting result was discussed according to densitometric analysis. Densitometric analysis was performed by scanning blots into a Power Macintosh 8100/100 computer with a Microtek ScanMaker Iisp scanner at a resolution of 150 lines per inch, with Adobe Photoshop 5.0 and NIH image 1.6.1 software.
Statistics
Data were analyzed statistically by Minitab Release 13.0 (Ozdamar 1995) . Comparisons between groups were made by the ANOVA GLM (General Linear Model) procedure.
Results
EPI cytotoxicity on H1299 WT and H1299 EPI(R) tumor cells
The resistant and sensitive H1299 cells were treated with different concentrations of EPI for 24 h. As shown in Figure 1 , the EPI(R) sub line was found to be more than 300-fold resistant to EPI than the parental WT cells. The IC50 values (5.5 ng/mL for WT cells and 1.6 µg/mL for EPI(R) cells) for EPI were determined by exposing to 3.5-8 ng/mL and 0.5-3.5 µg/mL EPI for the WT and EPI(R) cells, respectively. EPI (IC50 values) cytotoxicity was found lower in catalase (25%, 20%), SOD (25%, 18%) and catalase plus SOD (50%, 45%) pre-incubated H1299 WT and H1299 EPI(R) cells.
Susceptibility of H1299 WT and H1299 EPI(R) tumor cells to LAK cell-mediated cytotoxicity
Both the resistant and sensitive H1299 cells were treated with different numbers of LAK cells for 24 h. The IC50 values for LAK cells were 30 LAK/H1299 WT and 3 LAK/H1299 EPI(R) cells. In contrast to H1299 WT cells, H1299 EPI(R) cells exhibited an increased susceptibility to LAK cells. As shown in Figure 2 , the EPI(R) sub line was found to be 10-fold more sensitive to LAK cells than the parental WT cells. LAK (IC50 values) cytotoxicity was found lower in catalase (15%, 11%), SOD (18%, 15%) and catalase plus SOD (40%, 35%) pre-incubated H1299 WT and H1299 EPI(R) cells. (Fig. 3) . Pre-incubation of H1299 WT and H1299 EPI(R) cells with antioxidants for 30 min, before EPI (1 ng/mL and 0.5 µg/mL respectively for 24 h) plus LAK cells (25 LAK cells/H1299 WT, 2.5 LAK / H1299 EPI(R) cells) treatment decreased the cytotoxicity (SOD: 59%, 63%; catalase: 40%, 49%; SOD plus catalase: 70%, 76%). It is proposed here that, both EPI and LAK caused the production of reactive oxygen species in H1299 cells. SOD, catalase, GSH-Px, GST, and GSH must be considered as parts of the intracellular antioxidant defense mechanism of H1299 cells against single electron reducing quinone-containing anticancer antibiotics, such as EPI, and NO producing agents, such as LAK cells. Both of these therapeutic measures may cause production of free radicals in the cancer cells.
Susceptibility of H1299 WT and H1299 EPI(R) tumor cells to LAK cells + EPI cytotoxicity
Biochemical parameters of H1299 WT and H1299 EPI(R) tumor cells
We examined a number of enzymatic and biochemical variables that might influence either the activation of EPI or the detoxification of reactive forms of oxygen in H1299 WT and H1299 EPI(R) cells. In fact, several of the enzymatic activities were previously measured in sonicated tumor cells. We decided to examine more closely the selected enzymes in purified subcellular fractions to determine if subtle differences exist between the sensitive and drug-resistant tumor cells. The biochemical and enzymatic measurements are summarized in Table 1 . The activity of NADPH-CYP reductase, known to activate EPI, was found higher in the resistant cells. This might be due to a compensatory mech- anism. The resistance of H1299 EPI(R) cells to EPI appears to be associated with a developed tolerance to free radicals, most likely because of a 2-fold increase in NADPH-CYP reductase activity, 11-fold GST activity and 11-and 7-fold augmented Se-dependent and independent GSH-Px activity, respectively. The increased activity of GSH-Px in the H1299 EPI(R) would theoretically confer upon the resistant cells an increased capability to detoxify EPI free radical-enhanced or glucose oxidase-generated hydrogen peroxide. Of note, is the measurement that the resistant cells also had nearly 3-fold lower levels of reduced GSH, the cofactor for the transferase and peroxidase enzymes. However, the concentration of GSH in the resistant cells (about 3 mM) would still be sufficiently high to provide ample reduced GSH to both GST and GSH-Px.
The expression of GST-Pi
Western blot analysis was performed to demonstrate GST-pi expression of H1299 WT and H1299 EPI(R) cells. The expression of GST-pi was found to be much higher in H1299 EPI(R) cells than H1299 WT cells (Fig. 4) . Amount of GST-pi in H1299 EPI(R) cells is statistically different from negative control and H1299 WT (p < 0.01).
Discussion
Tumors are heterogeneous in many respects, including chemotherapeutic susceptibility and sensitivity to immune effector cell lysis. Resistance to chemotherapy and/or a lack of sensitivity to immune cell killing play a key role in therapy failures in many tumors (Rihova et al. 2002) . LAK cells secrete inflammatory cytokines that can induce nitric oxide synthesis (Kwak et al. 2000) . NO free radicals destroy tumor cells by inhibiting the energy-producing Krebs cycle and electron transport activities as well as DNA synthesis (Synder & Bredt 1992) . EPI is an antracycline analogue, which may undergo one electron reduction and produce reactive reduced oxygen species, such as superoxide anion, hydroxyl radical, and hydrogen peroxide (Dobbs 1994) . EPI cytotoxicity was found higher in H1299 WT cells than in H1299 EPI(R) cells in this study (Fig. 1) . EPI(R) sub-line was found to be more than 300-fold resistant to EPI than parental WT cells. In another study, MCF7 EPI(R) sub-line was found to be more than 400-fold resistant to EPI than parental WT cells ). Combination of superoxide-and hydrogen peroxide-scavenging antioxidant enzymes and SOD offers better protection of small cell lung cancer cells against exogenous oxidants (Hao et al. 1994) .
H1299 EPI(R) cells exhibited more susceptibility to LAK cells than their parental cell. As shown in Figure 2 , the EPI(R) sub-line was found to be 10-fold more sensitive to LAK cells than parental WT cells. In the previous studies, four of four P-glycoprotein positive ovarian carcinoma cell line variants had higher sensitivity to LAK than their drug-sensitive counterparts (Savas et al. 1996) . In a recent study, LAK cell cytotoxicity against target cells was demonstrated in both early and late phases (Komatsu & Ishiguro 2003) . The results of a randomized study indicated that the survival rate of the IL-2, LAK adoptive immunotherapy group was significantly higher than that of the control group. In conclusion, IL-2, LAK adoptive immunotherapy is an effective and promising modality, which will compensate for the deficiencies of other therapies (Kimura et al. 1998 ). In our study, the efficiency of chemoimmunotherapy combination was demonstrated by the almost 1.5-fold augmentation in the cells susceptibility of H1299 WT cells than in H1299 EPI(R) cells to LAK cells with the addition of 1/10 of IC50 concentration of EPI.
In one study, docetaxel treatment of HT-29 colon carcinoma cells reinforced the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro (Grunberg et al. 1998) . In one clinical study where patients with breast cancer treated with docetaxel demonstrated a more pronounced effect on enhancing MRL, NK, LAK cell activity and IFNγ, IL-2, IL-6, and GM-CSF levels, as well as caused more potent reduction in IL-1 and TNFα levels when compared to those treated with paclitaxel (Tsavaris et al. 2002) . In another study, cisplatin induced fas expression in oesophageal cancer cell lines and enhanced cytotoxicity when com-A. Ozkan bined with LAK cells (Matsuzaki et al. 2000) . Cisdiamminedichloroplatin and 5-fluorouracil were indicated as potent inducers of cytokines and natural killer cell activity in vivo and in vitro (Okamoto et al. 1998 ). These results indicated that many anticancer agents at low doses could increase the sensitivity of cancer cells to LAK cells. This synergy would be useful in clinical practice. Various chemotherapeutics might change sialic acid content, that in turn effect the NK and LAK sensitivity of target cells (Benoist 1988) .
Previously, it was reported that augmentation of EPI cytotoxicity by cycloheximide were elevated in the sensitive and resistant cells (Furusawa et al. 1996) . The enzymatic differences between H1299 WT and H1299 EPI(R) cells are given in Table 1 . The activities of NADPH-CYP reductase, GST (11-fold) and GSH-Px (7 to 11 fold), and expression of GST-pi were found higher in H1299 EPI(R) than H1299 WT cells. Likewise, M38K cells treated with EPI had elevated GSHPx activity (Kinnula 1998 ) and the activity of NADPH CYP reductase was found to be almost twofold higher in the resistant cells (Runge et al. 2000) . The potential of novel drugs to induce GST activities in rat and human hepatoma was shown by Dierickx (1999) . In our study, GST-pi expression in H1299(R) cells was found to be higher than the H1299 WT cells (Fig. 4) . EPI induced the expression of GST-pi in H1299(R) cells.
In conclusion, lung tumor cells selected for acquired resistance to EPI in culture have concurrently developed a tolerance to superoxide and hydrogen peroxide, most likely because of elevated activities of enzymatic defenses against oxyradicals. Furthermore, free radical role in the cytotoxicity seems to be more prominent in H1299(R) cancers. In the clinic, we look for windows of opportunity. Differential LAK cells susceptibility together with differential oxygen radical enzyme content may provide us another long waited therapeutic window against cancer.
